Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,078.50    26.00 (2.47%)
Bid:
1,071.00
Ask:
1,072.00
Spread: 1.00 (0.093%)
Market Cap: £3.46b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

Q3 Trading Statement

6 Nov 2024 07:00

RNS Number : 0639L
Persimmon PLC
06 November 2024
 

 

6 November 2024

 Trading Statement

 

Trading in-line with expectations, on track to grow completions to c.10,500

 

Persimmon Plc is today providing an update on trading for the period since 1 July 2024.

 

Dean Finch, Group Chief Executive, commented:

 

"Positive momentum in the business continued over the summer months and we remain on track to deliver growth in completions to c.10,500 for the full year. Visitor numbers and enquiries remain strong and sales rates continue to be well ahead of the prior year. Our forward order book is up 17% on the prior year with the private average selling price robust. We continue to position the business for success, maintaining our focus on quality and customer service, and converting our land holdings into active developments."

 

Highlights

 

 2024

 2023

 

 

Net private sales rate per outlet1

0.70

0.51

Current forward sales position2

£2.02bn

£1.73bn

Of which private forward sales2

£1.45bn

£1.04bn

 

1 Net private sales rate per outlet per week for the period since 1 July to 3 November 2024 (5 November 2023). Excluding bulk sales 0.61 (2023: 0.47).

2As at 3 November 2024 (5 November 2023). Excludes completions in Q3.

 

Trading

The Group traded in-line with expectations during the period and we remain on track to deliver completions of c.10,500 for the full year. During the third quarter we delivered 1,416 homes (2023: 1,439) including a 3% increase in private homes to 1,267 (2023: 1,234) and 149 Partnership homes (2023: 205).

 

The net private sales rate per outlet was up 37% in the period since 1 July at 0.70, or 0.61 excluding bulk sales, with net year to date private reservations since 1 January up 24% on last year. Customer interest remains good across all regions, and our marketing campaigns continue to generate healthy online traffic and visitors to our sites. Affordability and value remain important to our customers. Affordability constraints, particularly for first-time buyers, have been helped by the initial reductions in interest rates and a greater availability of over 90% loan-to-value mortgage products on the market than a year ago.

 

Overall pricing held firm in the period, with incentives continuing to run around 4-5% on average. Our private forward sales position has increased 40% to £1.45bn, reflecting more stable market conditions in 2024 and supported by our strategy of reserving multi-year sales to our relationship investors at an early stage. The private average selling price in the forward order book has remained robust at c.£291,400 (30 June 2024: c.£290,660), and is 10% higher than in the forward order book at 31 December 2023 (c.£266,100) and 5% higher than this time last year (2023: c.£278,500).

 

Land spend in the third quarter was £123m (2023: £78m) of which £47m related to the settlement of land creditors. Our owned and under control land holdings stood at c.81,500 plots at 30 September 2024 (31 December 2023: 82,235 plots). We are currently seeing a good number of opportunities in the land market and the embedded margin of the land portfolio remains excellent. We continue to anticipate a cash balance of £100m-£200m at the end of the current financial year.

 

We are progressing with our fire safety remediation commitment, with works underway or complete on 72% of known developments. We continue to expect that the bulk of works will be completed over the course of the next two years. 

 

Outlook

Demand for our homes has continued into the autumn selling season, helped by improvements in customer sentiment as interest rates begin to reduce and affordability improves. We are on track to grow to c.10,500 homes this year, compared to 9,922 in 2023, of which 85% are already exchanged or completed (2023: 84%), with further growth in outlets and volume expected in 2025.

 

As we move into 2025, we remain optimistic about our growth prospects although the quantum and timing of future interest rate changes is uncertain and we continue to assess the implications of the recent Budget. We are seeing some signs of build cost inflation beginning to emerge in price negotiations for 2025 and are working closely with our supply chain to manage our costs, which will also be impacted by new building regulations and the employer national insurance increases announced in the recent Budget. We are seeking to mitigate the impact of these cost increases through robust commercial controls and other management actions.

 

Early announcements from the government around planning reforms have been encouraging. We look forward to the outcome from the consultation on the National Planning Policy Framework later this year.

 

We are well positioned for continuing market improvement with an excellent pipeline of new sites aligned to our three strong brands, and with the core Persimmon product offering quality at an affordable price point for our customers.

 

Our next scheduled update will be our 2024 Trading Update on 14 January 2025.

 

Persimmon will host a conference call with analysts at 09.00am today.

 

All participants must pre-register to join this conference using the Participant Registration link. Once registered, an email will be sent with important details for this conference, as well as a unique Registrant ID.

 

Participant registration page: https://register.vevent.com/register/BIc07454d397c64088b1317705b433e073.

 

For further information please contact:

Victoria Prior, Group IR Director

Anthony Vigor, Group Director of Strategic Partnerships and External Affairs

Olivia Peters

Teneo

Persimmon Plc 

persimmon@teneo.com

Tel: +44 (0) 1904 642199

Tel: +44 (0) 7902 771 008

 

 

Appendices:

1. Quarterly performance

 

Q3 2024

Q3 2023

Variance

Completions (homes)

1,416

1,439

-23

Private (homes)

1,267

1,234

+33

Partnership (homes)

149

205

-56

FTB % (private completions)

32%

32%

-

 

 

 

2. Forward sales1

 

 

 

 

3 November 2024

5 November 2023

Variance

 

Value

Homes

Value

Homes

Value

Homes

Private

£1.45bn

4,988

£1.04bn

3,733

+40%

+34%

Partnership

£0.57bn

3,587 

£0.69bn

4,449

-17% 

-19%

Total

£2.02bn

8,575

£1.73bn

8,182

+17%

+5%

 

1 As at 3 November 2024 (5 November 2023). Excludes completions in Q3.

 

Cautionary statements

Some of the information in this document may contain projections or other forward-looking statements regarding future events or the future financial performance of Persimmon Plc and its subsidiaries (the Group). You can identify forward-looking statements by the terms such as "expect", "believe", "anticipate", "estimate", "intend", "will", "could", "may" or "might", the negative of such terms or similar expressions. Persimmon Plc (the Company) wishes to caution you that these statements are only predictions and that actual events or results may differ materially and as such undue reliance should not be placed on these statements. The Company does not intend to update these statements to reflect events and circumstances occurring after the date hereof or to reflect the occurrence of unanticipated events. Many factors could cause the actual results to differ materially from those contained in projections or forward-looking statements of the Group, including among others, general economic conditions, the competitive environment as well as many other risks specifically related to the Group and its operations. Past performance of the Group cannot be relied on as a guide to future performance.

 

Please see the most recent Annual Report and Accounts of Persimmon plc and other disclosures through the Regulatory News Service ("RNS") for further details of risks, uncertainties and other factors relevant to the business and its securities.

 

The information in this trading statement is unaudited.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFLDLDLEIIS
Date   Source Headline
7th Nov 20197:00 amRNSThird Quarter Trading Statement
1st Nov 201912:18 pmRNSTotal Voting Rights
21st Oct 20193:09 pmRNSBoard Changes
17th Oct 20192:39 pmRNSDirector/PDMR Shareholding
15th Oct 201911:19 amRNSAdditional Listing
1st Oct 20192:37 pmRNSTotal Voting Rights
20th Aug 20198:41 amRNSHalf-year results - Amendment
20th Aug 20197:00 amRNSHalf-year Results
1st Aug 20195:40 pmRNSTotal Voting Rights
4th Jul 20197:00 amRNSTrading Update
11th Jun 20197:18 amRNSDirector/PDMR Shareholding
3rd Jun 20191:53 pmRNSBlock listing Interim Review
3rd Jun 20191:48 pmRNSTotal Voting Rights
23rd May 20191:07 pmRNSAdditional Listing
1st May 20194:22 pmRNSResult of AGM
1st May 201911:23 amRNSTotal Voting Rights
1st May 20197:00 amRNSTrading Update
17th Apr 20197:00 amRNSDirector Appointment
1st Apr 20191:42 pmRNSTotal Voting Rights
21st Mar 20197:00 amRNSCustomer Care Improvement Plan
18th Mar 20192:30 pmRNSAnnual Financial Report
12th Mar 20193:19 pmRNSAdditional Listing
4th Mar 20191:36 pmRNSDirector/PDMR Shareholding
1st Mar 20194:34 pmRNSTotal Voting Rights
26th Feb 20197:00 amRNSCEO Appointment
26th Feb 20197:00 amRNSFinal Results
1st Feb 20194:36 pmRNSTotal Voting Rights
15th Jan 20197:00 amRNSTrading Update
11th Jan 20195:55 pmRNSHolding(s) in Company
2nd Jan 201912:55 pmRNSTotal Voting Rights
11th Dec 201810:18 amRNSDirector/PDMR Shareholding
7th Dec 201812:04 pmRNSDirector/PDMR Shareholding
6th Dec 20184:53 pmRNSDirector/PDMR Shareholding
4th Dec 20183:25 pmRNSBlock listing Interim Review
3rd Dec 20183:50 pmRNSTotal Voting Rights
7th Nov 20187:00 amRNSCEO change
7th Nov 20187:00 amRNSThird Quarter Trading Statement
1st Nov 20184:35 pmRNSTotal Voting Rights
24th Oct 20185:39 pmRNSAdditional Listing
23rd Oct 20185:57 pmRNSEBT Share Purchase
19th Oct 20189:47 amRNSDirector/PDMR Shareholding
15th Oct 20184:08 pmRNSEBT Share Purchase
8th Oct 20184:36 pmRNSHolding(s) in Company
3rd Oct 20183:52 pmRNSEBT Share Purchase
1st Oct 20182:20 pmRNSTotal Voting Rights
19th Sep 201810:31 amRNSEBT Share Purchase
3rd Sep 201810:36 amRNSTotal Voting Rights
21st Aug 20187:00 amRNSHalf Year Results
1st Aug 20181:44 pmRNSTotal Voting Rights
5th Jul 20187:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.